PHARMA-BIO SERV, INC. (PBSV) Gross margin 2017–2025
PHARMA-BIO SERV, INC. (PBSV) gross margin by fiscal year — reported gross profit divided by reported revenue.
32.3%FY2025 · since FY2017: 28.9% → 32.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 32.3% | +5.9 pp |
| FY2024 | 26.5% | -3.4 pp |
| FY2023 | 29.8% | +4.7 pp |
| FY2022 | 25.2% | -1.5 pp |
| FY2021 | 26.6% | -4.3 pp |
| FY2020 | 30.9% | -0.7 pp |
| FY2019 | 31.7% | -0.3 pp |
| FY2018 | 32.0% | +3.1 pp |
| FY2017 | 28.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice